MZ, H., SH, A. A., Z, Z., & MN, H. (2011). Development of antiproliferative nanohybrid compound with controlled release property using ellagic acid as the active agent. Dove Medical Press.
Style de citation Chicago (17e éd.)MZ, Hussein, Al Ali SH, Zainal Z, et Hakim MN. Development of Antiproliferative Nanohybrid Compound with Controlled Release Property Using Ellagic Acid as the Active Agent. Dove Medical Press, 2011.
Style de citation MLA (8e éd.)MZ, Hussein, et al. Development of Antiproliferative Nanohybrid Compound with Controlled Release Property Using Ellagic Acid as the Active Agent. Dove Medical Press, 2011.
Attention : ces citations peuvent ne pas être correctes à 100%.